TRUPCR® Europe, based in Manchester (UK), offers a comprehensive portfolio of high-quality molecular diagnostic PCR assays. Test development is aligned with global references such as CDC guidelines, WHO standards, and European reference materials. The assays are validated across various platforms to ensure optimal adaptability and reliable results. A key advantage is the user-friendly handling of the kits, enabling straightforward and efficient test execution.
Supplier homepage: https://trupcr.com/
Qualitative and quantitative PCR kits
-
Individual markers or multiplex panels
-
Compatible with a variety of real-time PCR instruments
-
All-in-one format: Includes all required reagents and internal controls
- Software analysis available for selected products (Research Use Only)
Product Portfolio
Infektionskrankheiten:
- Respiratorische Erreger
- Bakterielle und fungale Erreger
- Sexuell übertragbare Erkrankungen
- Tropische Erkrankungen
- Gastroenteritische Infektionen
- Sepsis
-
Erreger mit antimikrobieller Resistenzen
Oncology:
Hematology-Oncology
PCR assays for the detection of IDH1/2, JAK2, PML-RARA, and many moreSolid Tumors
PCR assays for the detection of ALK fusions, ROS1 fusions, colorectal mutations (KRAS, NRAS & BRAF), and many more
Additional Areas:
- Human genetics
PCR assays for the detection of G1691A, G20210A, HLA-B27, and MTHFR mutations – available as individual tests or in a multiplex panel - Pharmacogenetics
PCR assays for the detection of DPYD mutations, TPMT mutations, MTHFR mutations, and additional related kits - Antibiotic resistance
Over 14 PCR assays for the detection of clinically relevant genes - Extraction kits
